Tech Center 1600 • Art Units: 1634 1682
This examiner grants 20% of resolved cases
Bradley L. Sisson in Art Unit 1634 has a high volume of 746 resolved cases. The allowance rate is 19.7 percent, which is quite low for Tech Center 1600. The interview lift is 20.5 percent. This data suggests that while the examiner is strict, an interview nearly doubles the chances of allowance relative to the baseline rate.
The median time to allowance is 1587 days. This long pendency, combined with the 19.7 percent allowance rate, indicates a difficult prosecution environment. Practitioners should consider the 20.5 percent interview lift as a critical component of their strategy to navigate the lengthy 1587-day timeline.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18530606 | METHODS AND SYSTEMS FOR REDUCING PHASING ERRORS WHEN SEQUENCING NUCLEICACIDS USING TERMINATION CHEMISTRY | Final Rejection | LIFE TECHNOLOGIES CORPORATION |
| 18342948 | METHOD OF GENERATING ARRAYS USING MICROFLUIDICS AND PHOTOLITHOGRAPHY | Final Rejection | 10x Genomics, Inc. |
| 17776769 | GENERATING CAPTURE PROBES FOR SPATIAL ANALYSIS | Non-Final OA | 10x Genomics, Inc. |
| 18652258 | METHOD OF DETECTING TARGET SUBSTANCE | Non-Final OA | TOPPAN HOLDINGS INC. |
| 18915941 | PROXIMITY DETECTION OF BIOMOLECULE INTERACTIONS | Non-Final OA | Singular Genomics Systems, Inc. |
| 17780833 | NUCLEIC ACID SEQUENCE MEASURING APPARATUS, NUCLEIC ACID SEQUENCE MEASURING METHOD, AND NON-TRANSITORY RECORDING MEDIUM | Final Rejection | Yokogawa Electric Corporation |
| 16770889 | MULTIPLEX LABELING OF MOLECULES BY SEQUENTIAL HYBRIDIZATION BARCODING WITH RAPID SWITCHING AND REHYBRIDIZATION OF PROBES | Non-Final OA | California Institute of Technology |
| 17171629 | ANTIMICROBIAL SUSCEPTIBILITY TESTING USING MICRODROPLETS | Final Rejection | Becton, Dickinson and Company |
| 17312248 | GENOMIC REARRANGEMENTS ASSOCIATED WITH PROSTATE CANCER AND METHODS OF USING THE SAME | Non-Final OA | CHILDREN'S MEDICAL CENTER CORPORATION |
| 17511353 | DETECTING MATERIALS IN A MIXTURE USING OLIGONUCLEOTIDES | Final Rejection | ILLUMINA, INC. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy